 analyses provide generally comparable results. In the most recent analysis from the Premier
Perspective Database that used propensity score matching, total hospital costs among asymptomatic patients
were 40% higher for CAS compared with CEA ($11,814 vs
$8378; P < .001); and 37% higher among symptomatic patients $19,426 vs $14,190; P < .001).6